Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,532,908
-$1,023,032 QoQ
Shares Held
60,776
-22.5% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#112
of 329 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. PCVX ranks #18 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in PCVX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,532,908 | 60,776 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,555,940 | 78,402 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,171,870 | 133,764 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,381,892 | 149,414 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,358,395 | 164,823 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,977,221 | 131,812 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $12,069,110 | 147,436 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,369,957 | 64,496 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,149,513 | 94,683 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,618,262 | 126,164 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,948,336 | 158,413 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $8,355,316 | 163,894 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,205,591 | 164,309 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,741,939 | 179,881 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $9,124,980 | 190,302 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,241,912 | 93,413 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,118,094 | 51,383 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,401,859 | 58,048 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,100,430 | 46,256 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $712,364 | 28,079 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,190,914 | 52,906 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,792,964 | 90,783 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $239,448 | 9,012 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||